Apitaf Life Science Private Limited - Due diligence report

A 360° intelligence report on Apitaf Life Science Private Limited: trust score, financial health, credit view, compliance, directors, growth…

2012-01-30 Shahjahanpur, Uttar Pradesh Active Unlisted Active Compliant
Share
AL Apitaf Life Science Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Apitaf Life Science Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
80/100
Trust Score
Low Risk

Apitaf Life Science Private Limited is assessed as Low Risk with a Trust Score of 80/100. Apitaf Life Science Private Limited is an active private limited indian non-government company incorporated in 2012, operating in the Chemicals sector. Reported revenue has declined across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.

Report generated on 16 Jul 2026 from the latest processed filings. Apitaf Life Science Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
80/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
75/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
70/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
30/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
55/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 3 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 30/100 Caution Indicated
  • Liabilities ≈ 38% EBITDA - stretched.
  • Open charges exceed net worth - secured lenders rank ahead.
  • Elevated gearing (D/E 1.42).
  • Profitable - internal accruals available.

Charges position: 2 open (30.00 Lakh) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
Indian Bank2 48.0 cr
Compliance Score: 75/100 Low Risk
  • Company status is Active as per MCA.
  • Last balance sheet is for Mar 2019 - filings overdue.
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
ABHIJAT MISHRA 01234567 Director 01/04/2018 6 yrs Approved
RUCHI MISHRA 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2017 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 55 · Distress 80
Growth signals & trust indicators
Profit expanded 2.1x year-on-year.
Net margin improved to 24%.
Operating for 14+ years.
Distress signals & risk flags
Statutory filings appear overdue.
2 open charge(s) registered - assets are encumbered.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence78/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment53/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 2 open charge(s) of 30.00 Lakh already registered.
  • Compliance record supports lending.
Investor view66/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 2 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 9 events
30 Sep 2019
Last AGM held
Annual general meeting
31 Mar 2019
Latest balance sheet
Filed with ROC
28 Feb 2019
Director ceased
CHANDAN SWAROOP SAXENA
Director ceased
SUNITA SAXENA
27 Feb 2019
Director appointed
ABHIJAT MISHRA (Additional Director)
Director appointed
RUCHI MISHRA (Additional Director)
04 Jun 2014
Charge created
Indian Bank - 15.00 Lakh
21 Jan 2013
Charge created
Indian Bank - 15.00 Lakh
30 Jan 2012
Incorporated
Registered with Roc Kanpur
10

Key Observations

Auto-generated from the data above
Revenue declined 0.86 over the last 2 financial year(s).
Net profit margin moved from 61% to 38%.
Debt-to-equity stands at 1.42 - leverage worth monitoring.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
2 active director(s) / partner(s); board looks stable and experienced.
Promoters hold a dominant controlling stake as per the FY 2017 annual return.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Medward Biologicals Private Limited U74999MH2016PTC282276 Sumthana, Maharashtra, India
Krista Life Sciences Private Limited U24233MP2014PTC032680 Jabalpur, Madhya Pradesh, India
Epo-Chemie Private Ltd U24110MH1982PTC027953 Thane, Maharashtra, India
Icolor Chem Tech Private Limited U24233GJ2015PTC083800 Ahmedabad, Gujarat, India
Vikasdaksh Industries Private Limited U24232GJ2015PTC081971 Ahmedabad, Gujarat, India
Nallengare Pharmaceuticlas Pvt Ltd U24231KL1983PTC003760 Trichur, Kerala, India
Dpd Drugs & Pharmaceuticals Private Limited U24233DL2013PTC259335 New Delhi, Delhi, India
Humane Clinic Private Limited U51397JK2006PTC002679 Na, Jammu & Kashmir, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Apitaf Life Science Private Limited before audits and certifications: compliance score 75/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Apitaf Life Science Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 30/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 55/100, margin trends, ownership structure and peer set for Apitaf Life Science Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 80/100, distress signals and MSME payment-delay disclosures - know whether Apitaf Life Science Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Apitaf Life Science Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Apitaf Life Science Private Limited an active company?

Apitaf Life Science Private Limited has MCA status “Active” with a compliance score of 75/100 (Low Risk).

Is Apitaf Life Science Private Limited financially healthy?

Apitaf Life Science Private Limited has a Financial Health Score of 70/100 (Moderate) based on its filed financial statements.

Should I do business with Apitaf Life Science Private Limited?

Its overall Trust Score is 80/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Apitaf Life Science Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.

Does Apitaf Life Science Private Limited have loans or charges against its assets?

2 open charge(s) are registered against its assets.

Is Apitaf Life Science Private Limited up to date with its ROC filings?

Last balance sheet is for Mar 2019 - filings overdue. Overall compliance score: 75/100 (Low Risk).

Is it risky to lend to Apitaf Life Science Private Limited?

Its Credit Risk Score is 30/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.